Mendelian Diseases among Roman Jews: Implications for the Origins of Disease Alleles
Carole Oddoux,
Encarnacion Guillen-Navarro,
Claudio DiTivoli,
Elvira DiCave Maria Roberta Cilio,
C. Mark Clayton,
Holly Nelson,
Kyriakie Sarafoglou,
Nicole McCain,
Hava Peretz,
Uri Seligsohn,
Lucio Luzzatto,
Khedouja Nafa,
Michael Nardi,
Margaret Karpatkin,
Ivona Aksentijevich,
Daniel Kastner,
Felicia Axelrod and
Harry Ostrer
Department of Pediatrics (C.O., E.G-N., C.M.C., H.N., K.S., N.M.,
M.N., M.K., F.A., H.O.), New York School of Medicine, New York, New
York 10016; Universita di Roma "La Sapienza" (C.D.), Rome, Italy;
Ospedale Israelitico (E.D.), Rome, Italy; Ospedale Bambino Gesú
(M.R.C.), Rome, Italy; Sourasky Medical Center (H.P.), Tel Aviv,
Israel; Institute of Thrombosis and Hemostasis, Department of
Hematology (H.P., U.S.), Chaim Sheba Medical Center, Tel-Hashomer,
Israel; Department of Human Genetics (L.L., K.N.), Memorial
Sloan-Kettering Cancer Center, New York, New York; and National
Institute of Arthritis and Musculoskeletal Disorders (I.A., D.K.),
National Institutes of Health, Bethesda, Maryland 20892
Address correspondence and requests for reprints to: Harry Ostrer, M.D., Human Genetics Program, Department of Pediatrics, New York University School of Medicine, 550 First Avenue, MSB 136, New York, New York 10016. E-mail: harry.ostrer{at}med.nyu.edu
The Roman Jewish community has been historically continuousin Rome
since pre-Christian times and may have been progenitorto the Ashkenazi
Jewish community. Despite a history of endogamyover the past 2000 yr,
the historical record suggests that therewas admixture with Ashkenazi
and Sephardic Jews during the MiddleAges. To determine whether Roman
and Ashkenazi Jews shared commonsignature mutations, we tested a group
of 107 Roman Jews, representing176 haploid sets of chromosomes. No
mutations were found forBloom syndrome, BRCA1, BRCA2, Canavan disease,
Fanconi anemiacomplementation group C, or Tay-Sachs disease. Two
unrelatedindividuals were positive for the 3849 + 10C->T cystic
fibrosismutation; one carried the N370S Gaucher disease mutation, and
onecarried the connexin 26 167delT mutation. Each of these wasshown
to be associated with the same haplotype of tightly linked
microsatellitemarkers as that found among Ashkenazi Jews. In addition,
14individuals had mutations in the familial Mediterranean fevergene
and three unrelated individuals carried the factor XI typeIII mutation
previously observed exclusively among AshkenaziJews. These findings
suggest that the Gaucher, connexin 26,and familial Mediterranean fever
mutations are over 2000 yrold, that the cystic fibrosis 3849 + 10kb
C->T and factorXI type III mutations had a common origin in Ashkenazi
and RomanJews, and that other mutations prevalent among Ashkenazi Jews
areof more recent origin.
This article has been cited by other articles:
G. Zadra, R. Asselta, M.L. Tenchini, G. Castaman, U. Seligsohn, P.M. Mannucci, and S. Duga Reply to: [Factor XI mutation and the origin of Ashkenazi Jews. Haematologica 2008; 93:e59]
Haematologica,
October 1, 2008;
93(10):
e60 - e60.
[Full Text][PDF]
G. Zadra, R. Asselta, M. L. Tenchini, G. Castaman, U. Seligsohn, P. M. Mannucci, and S. Duga Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians
Haematologica,
May 1, 2008;
93(5):
715 - 721.
[Abstract][Full Text][PDF]
C. Romualdi, D. Balding, I. S. Nasidze, G. Risch, M. Robichaux, S. T. Sherry, M. Stoneking, M. A. Batzer, and G. Barbujani Patterns of Human Diversity, within and among Continents, Inferred from Biallelic DNA Polymorphisms
Genome Res.,
April 1, 2002;
12(4):
602 - 612.
[Abstract][Full Text][PDF]
M. F. Hammer, A. J. Redd, E. T. Wood, M. R. Bonner, H. Jarjanazi, T. Karafet, S. Santachiara-Benerecetti, A. Oppenheim, M. A. Jobling, T. Jenkins, et al. Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes
PNAS,
June 6, 2000;
97(12):
6769 - 6774.
[Abstract][Full Text][PDF]